The US Tumor Ablation Market landscape, Procedure Volumes, Brand Perception and Future Outlook report is the first ever syndicated report that covers the standard of care, procedure volumes and physician perception of the medical devices used in tumor ablation procedures. The report is based on responses from performing physicians in Interventional Radiology departments from university hospitals, community teaching/non-teaching hospitals and private practice.
The number of tumor ablation procedures were estimated to be around 65,000 in 2019.The 5-year forecast of procedure volumes till 2022 along with the headwinds and tailwinds are covered comprehensively in the report. The report has details on tumor ablation modality and their usage to treat different cancer types. The report captures tumor ablation modalities such as radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, HIFU and IRE.
The report also highlights the Interventional Oncology care continuum and offers valuable insights on patient referrals pathway, hospital structure and utilization, physician treatment selection criteria, treatment guidelines and payer coverage.
The report provides physician’s brand perception and ranks medical device companies based on 15 KPI’s such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of device, cost effectiveness among others effecting brand usage have been covered
The report provides information on the trends such as growing awareness amongst referring specialist, clinical evidence and early cancer diagnosis and treatment due to advent of better diagnostic techniques. Impact of newer treatment methodologies such as cell and gene therapies on tumor ablation uptake, prospects of immunotherapy used as a combination therapy with tumor ablation are potential game changers to watch out for in the growing tumor ablation market.
This report will help tumor ablation devices companies understand the interventional oncology landscape in the US, the current and future procedure volumes, the brand perception, device usage trends, and challenges faced by interventionalists in the US. The report is a great resource to plan your market strategy to capitalize on upcoming trends and potential disruptors in the tumor ablation devices market.
The deliverable includes a 100+ slide MS PowerPoint report and an MS Excel-based 5-Year market forecast model.
Contact us for further details regarding the exclusive data and insights in the report or for an exploratory analyst walk through of the report.